Mid-trimester termination for fetal abnormality: Advantages of a new regimen using mifepristone and misoprostol
Hinshaw K, El-Refaey H, Rispin R, Templeton A. Mid-trimester termination for fetal abnormality: advantages of a new regimen using mifepristone and misoprostol. Br J Obstet Gynaecol 1995 102 : 559 560.
Termination of 2nd and 3rd trimester pregnancies with mifepristone and misoprostol
Jannet D, Aflak N, Abankwa A, Carbonne B, Marpeau L, Milliez J. Termination of 2nd and 3rd trimester pregnancies with mifepristone and misoprostol. Eur J Obstet Gynecol Reprod Biol 1996 70 : 159 163.
Midtrimester medical termination of pregnancy: A review of 1002 consecutive cases
Ashok PW, Templeton A, Wagaarachchi PT, Flett GMM. Midtrimester medical termination of pregnancy: a review of 1002 consecutive cases. Contraception 2004 69 : 51 58.
The efficacy of intravaginal misoprostol in second-trimester pregnancy termination: A randomized controlled trial
Dickinson JE, Godfrey M, Evans SF. The efficacy of intravaginal misoprostol in second-trimester pregnancy termination: a randomized controlled trial. J Matern Fetal Med 1998 7 : 115 119.
Mifepristone in second-trimester medical abortion: A randomized controlled trial
Kapp N, Borgatta L, Stubblefield P, Vragovic O, Moreno N. Mifepristone in second-trimester medical abortion: a randomized controlled trial. Obstet Gynecol 2007 10 : 1304 1310.
Factors influencing the duration of pregnancy termination with vaginal misoprostol for fetal abnormality
Dickinson JE, Doherty DA. Factors influencing the duration of pregnancy termination with vaginal misoprostol for fetal abnormality. Prenat Diagn 2009 29 (5 520 524.
Report of the WA Abortion Notification System. Perth, Western Australia. Department of Health
Straton J, Godman K, Gee V, Hu Q. Induced Abortion in Western Australia 1999-2005. Report of the WA Abortion Notification System. Perth, Western Australia : Department of Health, 2006.
Vascular changes in the human endometrium following the administration of the progesterone antagonist RU 486
Johannisson E, Oberholzer M, Swahn ML, Bygdeman M. Vascular changes in the human endometrium following the administration of the progesterone antagonist RU 486. Contraception 1989 39 : 103 117.
Induction of second trimester abortion (12-20 weeks) with mifepristone and misoprostol: A review of 386 consecutive cases
Goh SE, Thong KJ. Induction of second trimester abortion (12-20 weeks) with mifepristone and misoprostol: a review of 386 consecutive cases. Contraception 2006 73 : 516 519.
Optimization of third-stage management after second-trimester medical pregnancy termination
e1-7.
Dickinson JE, Doherty DA. Optimization of third-stage management after second-trimester medical pregnancy termination. Am J Obstet Gynecol 2009 201 (3 303. e1-7.
Surgical versus medical methods for second trimester induced abortion
Lohr PA, Hayes JL, Gemzell-Danielsson K. Surgical versus medical methods for second trimester induced abortion. Cochrane Database of Systematic Reviews 2008 CD006714 (1 doi:.